VIRCO PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VIRCO PHARMA
Largest movements
- Receivables within one year -€325,418
down €325,418 (-44.5%), from €731,369 to €405,951
of which Trade receivables: -€332,557
- Stocks and contracts +€66,923
up €66,923 (+23.8%), from €281,607 to €348,530
- Tangible fixed assets -€65,855
down €65,855 (-6.8%), from €974,699 to €908,844
of which Land and buildings: -€37,003
- Intangible fixed assets -€60,000
down €60,000 (-63.2%), from €95,000 to €35,000
- Cash +€48,236
up €48,236 (+29.7%), from €162,201 to €210,437
mainly Receivables within one year (+€325,418) and Depreciation (+€125,855)
- Trade debts -€316,818
down €316,818 (-52.2%), from €607,021 to €290,203
- Debts after one year -€129,193
down €129,193 (-15.8%), from €818,598 to €689,405
- Reserves +€109,402
up €109,402 (+30.9%), from €354,532 to €463,933
of which Distributable reserves: +€109,402
- Current portion of long-term debt -€28,920
down €28,920 (-19.5%), from €148,414 to €119,494
- Gross operating margin +€132,952
up €132,952 (+38.6%), from €344,849 to €477,802
- Taxes +€30,006
up €30,006 (+111%), from €27,123 to €57,129
- Other operating charges +€19,478
up €19,478 (+92.1%), from €21,142 to €40,620
- Financial charges +€12,735
up €12,735 (+48.6%), from €26,183 to €38,918
- Financial income -€6,903
down €6,903 (-26.2%), from €26,364 to €19,461
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,247,809 | €1,916,122 | -€331,688 | -14.8% |
| Fixed assets | 21/28 | €1,070,475 | €944,620 | -€125,855 | -11.8% |
| Intangible fixed assets | 21 | €95,000 | €35,000 | -€60,000 | -63.2% |
| Tangible fixed assets | 22/27 | €974,699 | €908,844 | -€65,855 | -6.8% |
| Land and buildings | 22 | €880,490 | €843,487 | -€37,003 | -4.2% |
| Plant, machinery and equipment | 23 | €17,750 | €13,295 | -€4,455 | -25.1% |
| Furniture and vehicles | 24 | €13,512 | €5,696 | -€7,816 | -57.8% |
| Leasing and similar rights | 25 | €62,947 | €46,367 | -€16,580 | -26.3% |
| Financial fixed assets | 28 | €775 | €775 | = | 0.0% |
| Current assets | 29/58 | €1,177,335 | €971,502 | -€205,833 | -17.5% |
| Stocks and contracts in progress | 3 | €281,607 | €348,530 | +€66,923 | +23.8% |
| Stocks | 30/36 | €281,607 | €348,530 | +€66,923 | +23.8% |
| Amounts receivable within one year | 40/41 | €731,369 | €405,951 | -€325,418 | -44.5% |
| Trade receivables | 40 | €566,065 | €233,508 | -€332,557 | -58.7% |
| Other amounts receivable | 41 | €165,304 | €172,443 | +€7,139 | +4.3% |
| Cash at bank and in hand | 54/58 | €162,201 | €210,437 | +€48,236 | +29.7% |
| Deferred charges and accrued income | 490/1 | €2,158 | €6,585 | +€4,427 | +205% |
| Total equity and liabilities | 10/49 | €2,247,809 | €1,916,122 | -€331,688 | -14.8% |
| Equity | 10/15 | €409,532 | €518,933 | +€109,402 | +26.7% |
| Contributions | 10/11 | €55,000 | €55,000 | = | 0.0% |
| Contributions outside capital | 11 | €55,000 | - | -€55,000 | |
| Other | 1109/19 | €55,000 | - | -€55,000 | |
| Reserves | 13 | €354,532 | €463,933 | +€109,402 | +30.9% |
| Non-distributable reserves | 130/1 | €0 | €0 | = | 0.0% |
| Reserves not available under the articles | 1311 | €0 | €0 | -€0 | -100% |
| Other | 1319 | - | €0 | +€0 | |
| Distributable reserves | 133 | €354,531 | €463,933 | +€109,402 | +30.9% |
| Amounts payable | 17/49 | €1,838,278 | €1,397,188 | -€441,089 | -24.0% |
| Amounts payable after more than one year | 17 | €818,598 | €689,405 | -€129,193 | -15.8% |
| Financial debts | 170/4 | €818,598 | €689,405 | -€129,193 | -15.8% |
| Amounts payable within one year | 42/48 | €1,019,257 | €707,200 | -€312,057 | -30.6% |
| Current portion of amounts payable after more than one year | 42 | €148,414 | €119,494 | -€28,920 | -19.5% |
| Trade debts | 44 | €607,021 | €290,203 | -€316,818 | -52.2% |
| Suppliers | 440/4 | €607,021 | €290,203 | -€316,818 | -52.2% |
| Taxes, remuneration and social security | 45 | €91,925 | €112,149 | +€20,223 | +22.0% |
| Taxes | 450/3 | €60,392 | €84,266 | +€23,874 | +39.5% |
| Remuneration and social security | 454/9 | €31,533 | €27,882 | -€3,651 | -11.6% |
| Other amounts payable | 47/48 | €171,897 | €185,354 | +€13,457 | +7.8% |
| Accrued charges and deferred income | 492/3 | €423 | €583 | +€160 | +37.9% |
| Non-recurring operating income | 76A | €5,268 | €0 | -€5,268 | -100% |
| Remuneration, social security and pensions | 62 | €127,421 | €125,339 | -€2,082 | -1.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €125,890 | €125,855 | -€35 | 0.0% |
| Other operating charges | 640/8 | €21,142 | €40,620 | +€19,478 | +92.1% |
| Gross operating margin | 9900 | €344,849 | €477,802 | +€132,952 | +38.6% |
| Operating profit (loss) | 9901 | €70,397 | €185,988 | +€115,591 | +164% |
| Financial income | 75/76B | €26,364 | €19,461 | -€6,903 | -26.2% |
| Recurring financial income | 75 | €26,364 | €19,461 | -€6,903 | -26.2% |
| Financial charges | 65/66B | €26,183 | €38,918 | +€12,735 | +48.6% |
| Recurring financial charges | 65 | €26,183 | €38,918 | +€12,735 | +48.6% |
| Profit (loss) for the period before taxes | 9903 | €70,578 | €166,530 | +€95,952 | +136% |
| Income taxes | 67/77 | €27,123 | €57,129 | +€30,006 | +111% |
| Profit (loss) for the period | 9904 | €43,455 | €109,402 | +€65,947 | +152% |
| Profit (loss) for the period to be appropriated | 9905 | €43,455 | €109,402 | +€65,947 | +152% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.